Head-To-Head Review: Hyperfine (NASDAQ:HYPR) and QT Imaging (NASDAQ:QTI)

Hyperfine (NASDAQ:HYPR) and QT Imaging (NASDAQ:QTI) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, earnings, risk, analyst recommendations, dividends, institutional ownership and profitability.

Insider and Institutional Ownership

15.0% of Hyperfine shares are held by institutional investors. Comparatively, 24.2% of QT Imaging shares are held by institutional investors. 29.4% of Hyperfine shares are held by insiders. Comparatively, 75.4% of QT Imaging shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Risk and Volatility

Hyperfine has a beta of 0.86, meaning that its stock price is 14% less volatile than the S&P 500. Comparatively, QT Imaging has a beta of -0.23, meaning that its stock price is 123% less volatile than the S&P 500.

Valuation and Earnings

This table compares Hyperfine and QT Imaging”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Hyperfine	$11.03 million	6.42	-$44.24 million	($0.57)	-1.70
QT Imaging	$4.00 million	2.72	-$4.03 million	N/A	N/A

QT Imaging has lower revenue, but higher earnings than Hyperfine.

Profitability

This table compares Hyperfine and QT Imaging’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Hyperfine	-309.42%	-57.54%	-50.38%
QT Imaging	N/A	N/A	-65.94%

Analyst Ratings

This is a breakdown of recent ratings for Hyperfine and QT Imaging, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Hyperfine	0	1	1	0	2.50
QT Imaging	0	0	0	0	0.00

Hyperfine currently has a consensus target price of $1.60, indicating a potential upside of 64.93%. Given Hyperfine’s stronger consensus rating and higher probable upside, analysts plainly believe Hyperfine is more favorable than QT Imaging.

Summary

Hyperfine beats QT Imaging on 7 of the 12 factors compared between the two stocks.

About Hyperfine

Hyperfine, Inc., a medical device company, provides magnetic resonance imaging (MRI) products in the United States. The company offers Swoop Portable MR imaging system, which offers portable brain neuroimaging; and support and technical assistance services. It serves ICU, comprehensive, and primary stroke accredited facilities through direct sales and distributors. Hyperfine, Inc. was founded in 2014 and is based in Guilford, Connecticut.

About QT Imaging

QT Imaging Holdings, Inc. engages in the research, development, and commercialization of body imaging systems for detection, diagnosis, monitoring, and treatment of diseases. The company offers QT Ultrasound Breast Scanner, an ultrasonic imaging system that provides reflection-mode and transmission-mode images of a patient’s breast. QT Imaging Holdings, Inc. was founded in 2011 and is based in Novato, California.